Anti-nuclear antibody (ANA) test is a systematic screening test that is used for the diagnosis of autoimmune disorders. The prevalence of anti-nuclear antibodies in a healthy individual is about 3% to 15%. As the production of autoantibodies is age-dependent, it increases from 10% to 37% over the age of 65. The ANA test provides auxiliary prognostics and diagnostics information about the nature of the autoimmune process on the basis of the targeted antigens. Around 95% of anti-nuclear antibody test is carried out for the diagnosis of Lupus autoimmune disease.
Market Research Future (MRFR) has recently availed a report on Anti-Nuclear Antibody (ANA) Testing Market suggesting the global ANA testing market is anticipated to reach US$ 1300.6 MN by 2023 at a significant CAGR of 9.6%.
Global Anti-Nuclear Antibody (ANA) Testing Market – Competitive Analysis
The evolution in technology has opened a broad pathway for the prominent players in the global anti-nuclear antibodies testing market to introduce innovative techniques in the healthcare sector. Some of the key players in the ANA testing market are Merck KGaA (Germany), Trinity Biotech (Republic of Ireland), Abcam plc. (US), Alere (US), Antibodies Inc.(US), Bio-Rad Laboratories, Inc. (US), Erba Diagnostics (US), Indur Services, Inc. (US), MBL INTERNATIONAL (US) among others.
Global Anti-Nuclear Antibody (ANA) Testing Market – Market Drivers
The increasing healthcare awareness and rising prevalence of autoimmune diseases such as rheumatoid arthritis, type I diabetes and more are acting as some of the major driving forces acting on the global ANA testing market. Government healthcare policies and increase in healthcare expenditure on the global level are fuelling the expansion of the global ANA market. The rapid technological advancement and adoption of innovative techniques in the healthcare sector are also driving the ANA testing market. The increase in government campaigns to provide public awareness regarding autoimmune disorders is inclining the population towards seeking clinical diagnostic from time to time which is leading to the growth of the ANA testing market on a global level.
Global Anti-Nuclear Antibody (ANA) Testing Market – Market Restraints
Lack of skilled technicians, strict regulatory framework for product approval and diagnostic errors are considered to hamper the growth of global anti-nuclear antibodies (ANA) testing market.
Global Anti-Nuclear Antibody (ANA) Testing Market – Intended Audience
- Anti-nuclear Antibody (ANA) Test products manufacturers
- Anti-nuclear Antibody (ANA) Test products and services providers
- Medical Research laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/3210 .
Global Anti-Nuclear Antibody (ANA) Testing Market – Segments
The Global Anti-Nuclear Antibodies Testing Market has been segmented on the basis of type, application and end-users. On the basis of type, the global ANA testing market is segmented into immunofluorescence (primary or direct and secondary or indirect), enzyme-linked, immunosorbent assay (ELISA) (direct ELISA, indirect ELISA, sandwich ELISA, competition/inhibition ELISA), and others.
On the basis of application, the ANA market is segmented into rheumatoid arthritis (seropositive, seronegative), systemic lupus erythematosus (SLE) (discoid lupus erythematosus, subacute cutaneous lupus erythematosus, neonatal lupus), polymyositis, scleroderma (localized scleroderma, systemic scleroderma), sjögren’s syndrome (primary, secondary), and others.
On the basis of end-users, the market is segmented into hospitals and clinics, research laboratories, and others.
Global Anti-Nuclear Antibody (ANA) Testing Market – Regional Analysis
Geographically, the anti-nuclear antibodies testing market has been segmented into major regions such as North America, Europe, Asia-Pacific (APAC) and Middle East and Africa. Due to a large number of geriatric population, well-developed healthcare infrastructure, rise in the number of autoimmune diseases such as Lupus and early diagnostic of these diseases in North America, this region is currently dominating the global anti-nuclear antibodies (ANA) testing market. Europe is considered to be following North America with a large ANA testing market. The rapid rise in the population, increasing health awareness in public, improvement in healthcare infrastructure and increasing prevalence of autoimmune disorders in leading to the significant growth of ANA testing market in Asia-Pacific region, making it a fastest growing market in the world. Whereas, limited growth of the ANA testing market is observed in the regions of Middle East and Africa due to lack of awareness of health, treatments and devices.
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/3210
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar